Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

PP405 may damage hair follicles if used long-term, suggesting cycling might be necessary. Combining it with finasteride could help maintain hair growth.

PP405 trials have completed phase 2a, showing promising results with a 31% stat for hair density increase, and are moving directly to phase 3. Detailed results will be presented at a medical conference in 2026.

A user shared their hair loss journey, using finasteride since age 18 and adding dutasteride at 30, which halted hair loss and promoted regrowth. They take finasteride daily and dutasteride three times a week, experiencing reduced libido and drier skin as side effects.

Finasteride improved hair thickness and stopped hair loss without side effects. Results appeared around three months, with no shedding reported.

The conversation is about hair regrowth using finasteride and minoxidil, with users noting visible new hair growth and discussing dosages. Some users express encouragement and hope, while one advises against using finasteride.

A 34-year-old male experienced significant hair regrowth and increased density after 20 months of using 1.25 mg of finasteride daily, with no noticeable side effects. He did not use minoxidil due to adverse effects and plans to consider adding dutasteride weekly for further improvement.

RU58841 may help some with hair loss, but it can have side effects like heart pain. Dutasteride and finasteride can cause initial shedding, and results may take time.

A 24-year-old shares their positive 4-month progress using 0.5 mg oral finasteride and 5% topical minoxidil for hair loss, reporting no significant side effects. Other users discuss similar experiences and regimens, with some expressing concerns about potential side effects.

User creates 0.1% topical finasteride solution using Alfatradiol Avixis base. Seeks help to ensure alfatradiol base dissolves finasteride.

The conversation is about trying PTD-DBM for hair loss treatment. Users are curious about its effectiveness and results.

The conversation is about using PTD-DBM Peptide from Infiniwell for hair loss. The original poster is seeking feedback on its effectiveness.

The user experienced significant hair regrowth and improved hair density after four months using finasteride, minoxidil, and microneedling, avoiding the need for a hair transplant. They plan to continue their current routine due to positive results and are not considering switching to dutasteride.

A 33-year-old user is seeking advice on adjusting their hair loss treatment, which includes daily finasteride, oral minoxidil, and various supplements. They are considering switching to alternate-day dosing of finasteride or dutasteride and are concerned about potential shedding and effectiveness.

The user switched from finasteride to dutasteride and oral minoxidil after experiencing side effects and worsening hair on finasteride. They report improved hair health with dutasteride and oral minoxidil, noting no side effects with dutasteride.

Finasteride has no effect on the user's estradiol levels, and body fat may influence aromatization. The user is on testosterone replacement therapy and uses everyday injections to manage high RBC count, with plans to measure DHT, DHEA-S, and pregnenolone levels.

A user shared their 4-month progress using minoxidil foam twice daily and 1 mg finasteride tablets, showing significant hair growth. The user reported no side effects from finasteride and used Propecia, the only available brand in their region.

The user experienced significant hair regrowth using dutasteride (0.5 mg three times a week) and RU58841 (5% once a day), with no side effects reported from RU58841. They are considering increasing the RU58841 dose or adding minoxidil for further improvement.

A long-term finasteride user is considering switching to dutasteride due to hair loss progression. Users share experiences with switching, noting side effects and varying effectiveness, with some experiencing shedding and others maintaining their hairline.

The conversation is about a user experiencing small hair regrowth after 4 weeks of using oral Minoxidil and Dutasteride, and considering a future FUE transplant. Some users express skepticism about the regrowth, while others share similar experiences or doubts about the effectiveness of the treatment.

The user is taking finasteride and minoxidil for hair loss, but their DHT levels are unusually high, leading to suspicion of lab errors. They plan to retest at a different lab to confirm results.

The user is considering RU58841 and has been using dutasteride since age 17. They are seeking affordable SARD options, mentioning ASC-J9, GT20029, and AH001.

The user started taking 0.5 mg of finasteride every other day for hair thinning, experienced minimal side effects, and noticed reduced shedding and slightly thicker hair. They considered using minoxidil but decided against it due to having a dog.

The user shared a 4-month update on using oral finasteride, oral minoxidil, and vitamins for hair regrowth, with occasional derma-rolling. They experienced initial shedding but saw significant hair growth, including facial hair.

The conversation discusses the use of RU58841 for hair loss, with concerns about its legality in Germany and potential legal consequences. Alternatives like finasteride and dutasteride are mentioned, with some users questioning the effectiveness and safety of RU58841.

Finasteride helped maintain hair density and prevent further hair loss over 4.5 years, with no major side effects except mild gynecomastia. Consistency and regular health checks are recommended, and the user experienced stable hair density with occasional shedding.

The user experienced a sudden and severe hair loss after 1.5 years of successful treatment with finasteride and minoxidil. They plan to check their thyroid and vitamin D levels as potential causes.

The FDA will now require only one clinical trial for drug approval, potentially speeding up the release of hair loss treatments like PP405. Pelage is expected to present full results of PP405 Phase 2a trials and move to Phase III in mid-2026.

A 23-year-old with hair loss uses finasteride, minoxidil, and other treatments, considering adding dutasteride due to hairline recession. They seek advice on dutasteride's effectiveness and sourcing.

A user reduced their finasteride dose from 1.25 mg to 0.5 mg due to side effects like decreased libido and lack of interest in hobbies. They noticed some hair loss but experienced a slight improvement in side effects and plan to continue with the lower dose.

The user experienced thicker hair after 4.5 months using oral finasteride, oral and topical minoxidil, biotin, magnesium, zinc, vitamin D, iodine, and head massages. They also noticed improved muscle gains at the gym, possibly linked to finasteride.